Unknown

Dataset Information

0

T-cell responses and therapies against SARS-CoV-2 infection.


ABSTRACT: Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, a novel coronavirus strain. Some studies suggest that COVID-19 could be an immune-related disease, and failure of effective immune responses in initial stages of viral infection could contribute to systemic inflammation and tissue damage, leading to worse disease outcomes. T cells can act as a double-edge sword with both pro- and anti-roles in the progression of COVID-19. Thus, better understanding of their roles in immune responses to SARS-CoV-2 infection is crucial. T cells primarily react to the spike protein on the coronavirus to initiate antiviral immunity; however, T-cell responses can be suboptimal, impaired or excessive in severe COVID-19 patients. This review focuses on the multifaceted roles of T cells in COVID-19 pathogenesis and rationalizes their significance in eliciting appropriate antiviral immune responses in COVID-19 patients and unexposed individuals. In addition, we summarize the potential therapeutic approaches related to T cells to treat COVID-19 patients. These include adoptive T-cell therapies, vaccines activating T-cell responses, recombinant cytokines, Th1 activators and Th17 blockers, and potential utilization of immune checkpoint inhibitors alone or in combination with anti-inflammatory drugs to improve antiviral T-cell responses against SARS-CoV-2.

SUBMITTER: Toor SM 

PROVIDER: S-EPMC7730020 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

T-cell responses and therapies against SARS-CoV-2 infection.

Toor Salman M SM   Saleh Reem R   Sasidharan Nair Varun V   Taha Rowaida Z RZ   Elkord Eyad E  

Immunology 20201027 1


Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, a novel coronavirus strain. Some studies suggest that COVID-19 could be an immune-related disease, and failure of effective immune responses in initial stages of viral infection could contribute to systemic inflammation and tissue damage, leading to worse disease outcomes. T cells can act as a double-edge sword with both pro- and anti-roles in the progression of COVID-19. Thus, better understanding of their roles in immune responses to  ...[more]

Similar Datasets

| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other
| S-SCDT-10_15252-EMBR_202256374 | biostudies-other
| S-EPMC9255948 | biostudies-literature
| S-SCDT-EMBOJ-2021-109622 | biostudies-other
| S-EPMC7402670 | biostudies-literature
| S-EPMC10058409 | biostudies-literature
2010-02-01 | GSE17400 | GEO
2023-07-12 | GSE233548 | GEO
2010-02-24 | E-GEOD-17400 | biostudies-arrayexpress
| S-EPMC8140108 | biostudies-literature